Deutsche Bank analyst George Hill lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps a Hold rating on the shares post the Q3 report.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX: